Sen. Klobuchar calls out Rising Pharma for price-gouging an old generic drug in shortage
07 Dec 2023
Minnesota Democrat Sen. Amy Klobuchar sent a letter on Thursday to Rising Pharmaceuticals over the company’s decision to price its generic drug to treat lead poisoning at $32,000, which has led hospitals to no longer afford it or carry it.
While the FDA allowed Rising to bring this polyvalent ion chelator, known as edetate calcium disodium, to alleviate a shortage, Klobuchar notes that its price is “ten times the price of the imported version from France,” which is leading to access issues.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.